[go: up one dir, main page]

GB201211395D0 - A method for diagnosing or determining the prognosis of colorectal cancer (crc) using novel autoantigens: gene expression guided autoantigen discovery - Google Patents

A method for diagnosing or determining the prognosis of colorectal cancer (crc) using novel autoantigens: gene expression guided autoantigen discovery

Info

Publication number
GB201211395D0
GB201211395D0 GBGB1211395.7A GB201211395A GB201211395D0 GB 201211395 D0 GB201211395 D0 GB 201211395D0 GB 201211395 A GB201211395 A GB 201211395A GB 201211395 D0 GB201211395 D0 GB 201211395D0
Authority
GB
United Kingdom
Prior art keywords
prognosis
crc
diagnosing
determining
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1211395.7A
Other versions
GB2494741B (en
GB2494741A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ambergen Inc
Original Assignee
Ambergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/533,036 external-priority patent/US20130022987A1/en
Application filed by Ambergen Inc filed Critical Ambergen Inc
Publication of GB201211395D0 publication Critical patent/GB201211395D0/en
Publication of GB2494741A publication Critical patent/GB2494741A/en
Application granted granted Critical
Publication of GB2494741B publication Critical patent/GB2494741B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • G01N33/57535—
    • G01N33/5758—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB1211395.7A 2011-06-27 2012-06-27 A method for diagnosing or determining the prognosis of colorectal cancer (crc) using novel autoantigens: gene expression guided autoantigen discovery Expired - Fee Related GB2494741B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161501466P 2011-06-27 2011-06-27
US13/533,036 US20130022987A1 (en) 2011-06-27 2012-06-26 Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery

Publications (3)

Publication Number Publication Date
GB201211395D0 true GB201211395D0 (en) 2012-08-08
GB2494741A GB2494741A (en) 2013-03-20
GB2494741B GB2494741B (en) 2013-11-06

Family

ID=46704290

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1211395.7A Expired - Fee Related GB2494741B (en) 2011-06-27 2012-06-27 A method for diagnosing or determining the prognosis of colorectal cancer (crc) using novel autoantigens: gene expression guided autoantigen discovery

Country Status (1)

Country Link
GB (1) GB2494741B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021358002A1 (en) * 2020-10-05 2023-06-08 Freenome Holdings, Inc. Markers for the early detection of colon cell proliferative disorders
CN120559235A (en) * 2025-02-13 2025-08-29 浙江大学 A biomarker for early colorectal cancer detection and its application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719808D0 (en) * 2007-10-10 2007-11-21 Jenkins D P Method
WO2009114836A1 (en) * 2008-03-14 2009-09-17 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
WO2010042228A2 (en) * 2008-10-10 2010-04-15 Cornell University Methods for predicting disease outcome in patients with colon cancer

Also Published As

Publication number Publication date
GB2494741B (en) 2013-11-06
GB2494741A (en) 2013-03-20

Similar Documents

Publication Publication Date Title
IL276488A (en) A method for predicting the prognosis of breast cancer
IL219405A0 (en) Diagnostic methods for determining prognosis of non-small cell lung cancer
EP2883965B8 (en) Method for determining copy number variations
WO2011163332A9 (en) Methods for detecting cancer
GB201021289D0 (en) Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
IL225620A0 (en) Micrornas (mirna) as biomakers for the identification of familial and non-familial colorectal cancer
ZA201400089B (en) Methods and nucleic acids for determining the prognosis of a cancer subject
PL2714926T3 (en) Biomarkers for lung cancer
PL2558854T3 (en) Breast cancer associated circulating nucleic acid biomarkers
PL2576837T3 (en) Prostate cancer associated circulating nucleic acid biomarkers
WO2012030840A9 (en) Gene signatures for cancer diagnosis and prognosis
GB201102014D0 (en) Method for predicting risk of developing cancer
PL2768985T3 (en) Colorectal cancer associated circulating nucleic acid biomarkers
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
ZA201300519B (en) Novel antibody for the diagnosis and/or prognosis of cancer
WO2012012225A9 (en) Predicting cancer outcome
IL222533A0 (en) Methods for detecting antibodies
ZA201703026B (en) Biomarkers for the prediction of incident cancer
EP2744919A4 (en) Gene signatures for lung cancer prognosis and therapy selection
GB201012590D0 (en) Methods for diagnosing cancer
EP2521730A4 (en) Gene biomarkers of lung function
IL227419A0 (en) Prognostic signature for colorectal cancer recurrence
GB2494580B (en) Method for diagnosing lung cancer
WO2012167112A9 (en) Gastric cancer biomarkers
PL2444811T3 (en) Methods for the diagnosis or prognosis of colorectal cancer

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20160627